Q-omics provides the consensus-scored C22orf31 profile across patient tissues and cancer cell-line models. C22orf31 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in SCLC. Additionally, C22orf31 RNA expression shows 10,222 significant protein co-abundance associations, with the highest sampling consensus in HNSC. Together, these results highlight SCLC, and HNSC as cancer lineages where C22orf31 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.